Difference between revisions of "Sidik"

(Imported from Wikispaces)
 
Line 1: Line 1:
 +
 
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 130%;">'''Hyperbaric oxygen administration decreased side effects and improved quality of life after pelvic irradiation in women.'''</span>
 
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 130%;">'''Hyperbaric oxygen administration decreased side effects and improved quality of life after pelvic irradiation in women.'''</span>
  
 
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Bottom line'''</span>
 
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Bottom line'''</span>
−
# <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Hyperbaric oxygen improved symptoms and signs of radiation proctitis in women following pelvic irradiation for cervical cancer.</span>
 
−
# <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">There was an improvement in both proctosopic and histological findings following HBOT. </span>
 
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Citations'''</span>
+
#<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Hyperbaric oxygen improved symptoms and signs of radiation proctitis in women following pelvic irradiation for cervical cancer.</span>
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">1. Sidik S, Hardjodisastro D, Setiabudy R, Gondowiardjo S. Does hyperbaric oxygen administration decrease side effect and improve quality of life after pelvic radiation? ''Acta Med Indones'' 2007;39(4):169-173.</span>
+
#<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">There was an improvement in both proctosopic and histological findings following HBOT.</span>
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">2. Sidik S, Daldiyono H, Setiabudy R, Gondowiardjo S, Yoewona V. Oxygen hyperbaric therapy in patients with radiation proctitis. ''The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy'' 2007;8(1):1-4.</span>
+
 
 +
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Citations'''</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">1. Sidik S, Hardjodisastro D, Setiabudy R, Gondowiardjo S. Does hyperbaric oxygen administration decrease side effect and improve quality of life after pelvic radiation? ''Acta Med Indones'' 2007;39(4):169-173.</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">2. Sidik S, Daldiyono H, Setiabudy R, Gondowiardjo S, Yoewona V. Oxygen hyperbaric therapy in patients with radiation proctitis. ''The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy'' 2007;8(1):1-4.</span>
 +
 
 +
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Three-part clinical question'''</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">For patients with radiation proctitis following radiotherapy for cervical cancer, does hyperbaric oxygen therapy result in improvement of quality of life and objective evidence of radiation proctitis?</span>
 +
 
 +
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Search Terms'''</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Hyperbaric oxygen therapy, radiation proctitis, quality of life</span>
 +
 
 +
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''The study'''</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Non-blinded randomised controlled trial, intention to treat unclear</span>
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Three-part clinical question'''</span>
+
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''The study patients'''</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Adult females (<55 years) with cervical cancer stages I – IIIB and irradiation (ex beam and brachytherapy) who had radiation proctitis 1 to 6 months after radiotherapy.</span>
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">For patients with radiation proctitis following radiotherapy for cervical cancer, does hyperbaric oxygen therapy result in improvement of quality of life and objective evidence of radiation proctitis?</span>
 
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Search Terms'''</span>
+
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Control group''': (n=40, 20 analysed) received standard care (not defined),</span>
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Hyperbaric oxygen therapy, radiation proctitis, quality of life</span>
 
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''The study'''</span>
+
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Experimental group''': (n=35, 26 analysed) as above plus HBOT (regimen not given but minimum 18 sessions).</span>
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Non-blinded randomised controlled trial, intention to treat unclear </span>
 
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''The study patients'''</span>
+
&nbsp;
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Adult females (<55 years) with cervical cancer stages I – IIIB and irradiation (ex beam and brachytherapy) who had radiation proctitis 1 to 6 months after radiotherapy. </span>
 
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Control group''': (n=40, 20 analysed) received standard care (not defined), </span>
 
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Experimental group''': (n=35, 26 analysed) as above plus HBOT (regimen not given but minimum 18 sessions). </span>
 
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''The evidence'''</span>
+
<span style="font-size:large;"><span style="font-family: Arial, Helvetica, sans-serif;">'''The evidence:'''</span></span>
  
−
{|  
+
{| class="Table" style="border:solid windowtext 1.0pt"
−
| <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Outcome'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Time to outcome'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Control Group'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Experimental Group'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''P value'''</span></span>
 
 
|-
 
|-
−
| <span style'''"font-family: Arial,Helvetica,sans-serif; font-size: 110%;">Absence of radiation proctitis </span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">6 months</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">9/20 ''' 0.45</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">20/26 ''' 0.77</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">0.026</span></span><br><span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">(NNT ''' 3)</span></span>  
+
| style="border:solid windowtext 1.0pt" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Outcome</span></span>'''</span>
 +
 
 +
| style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to outcome</span></span>'''</span></p>  
 +
| style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Control Group</span></span>'''</span></p>  
 +
| style="width:94.5pt; border:solid windowtext 1.0pt" width="128" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Experimental Group</span></span>'''</span></p>
 +
| style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">P value</span></span>'''</span></p>  
 
|-
 
|-
 +
| style="border:solid windowtext 1.0pt" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Absence of radiation proctitis</span></span>'''</span>
 +
 +
| style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6 months</span></span></span></p>
 +
| style="border:solid windowtext 1.0pt" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">9/20 (45%)</span></span></span></p>
 +
| style="width:94.5pt; border:solid windowtext 1.0pt" width="128" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">20/26 (77%)</span></span></span></p>
 +
| style="width:51.9pt; border:solid windowtext 1.0pt" width="72" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.03<br/> (NNT 3''')'''</span></span></span></p>
 
|}
 
|}
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 110%;">'''Non-event outcomes'''</span>
+
<span style="line-height:normal">'''<span style="font-size:13.0pt"><span style="font-family:" arial",sans-serif"="">Non-event outcomes</span></span>'''</span>
  
−
{|  
+
{| class="Table" style="border:solid windowtext 1.0pt"
−
| <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Outcome'''</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Time to outcome'''</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Control Group'''</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''Experimental Group'''</span> || <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">'''P value'''</span>
 
 
|-
 
|-
−
| <span style'''"font-family: Arial,Helvetica,sans-serif; font-size: 110%;">Percentage change in LENT SOMA Score compared to before intervention</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">After intervention</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">44.12+/- 28.22</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">0.71 +/- 30.16</span> || <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">< 0.001</span>  
+
| style="width:167.6pt; border:solid windowtext 1.0pt" width="226" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Outcome</span></span>'''</span>
 +
 
 +
| style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to outcome</span></span>'''</span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Control Group</span></span>'''</span></p>
 +
| style="width:83.55pt; border:solid windowtext 1.0pt" width="113" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Experimental Group</span></span>'''</span></p>
 +
| style="width:44.8pt; border:solid windowtext 1.0pt" width="63" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">P value</span></span>'''</span></p>  
 
|-
 
|-
−
| <span style'''"font-family: Arial,Helvetica,sans-serif; font-size: 110%;">Percentage change in LENT SOMA Score compared to before intervention</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">6 months</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">33.64 +/- 57.64</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">-19.69 +/- 69.44</span> || <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">0.008</span>  
+
| style="width:167.6pt; border:solid windowtext 1.0pt" width="226" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Percentage change in LENT SOMA Score compared to before intervention</span></span>'''</span>
 +
 
 +
| style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">After intervention</span></span></span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">44.1+/- 28.2</span></span></span></p>
 +
| style="width:83.55pt; border:solid windowtext 1.0pt" width="113" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.71 +/- 30.2</span></span></span></p>
 +
| style="width:44.8pt; border:solid windowtext 1.0pt" width="63" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">< 0.001</span></span></span></p>  
 
|-
 
|-
−
| <span style'''"font-family: Arial,Helvetica,sans-serif; font-size: 110%;">Percentage change in Karnofsky Score compared to before intervention</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">After intervention</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">19.67 +/- 9.64</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">4.53 +/- 10.74</span> || <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">< 0.001</span>  
+
| style="width:167.6pt; border:solid windowtext 1.0pt" width="226" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Percentage change in LENT SOMA Score compared to before intervention</span></span>'''</span>
 +
 
 +
| style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6 months</span></span></span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">33.6 +/- 57.6</span></span></span></p>
 +
| style="width:83.55pt; border:solid windowtext 1.0pt" width="113" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">-19.7 +/- 69.4</span></span></span></p>
 +
| style="width:44.8pt; border:solid windowtext 1.0pt" width="63" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.008</span></span></span></p>  
 
|-
 
|-
−
| <span style'''"font-family: Arial,Helvetica,sans-serif; font-size: 110%;">Percentage change in Karnofsky Score compared to before intervention</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">6 months</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">15.27 +/- 14.74</span> || <span style'''"display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">2.47 +/- 16.11</span> || <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;">0.007</span>  
+
| style="width:167.6pt; border:solid windowtext 1.0pt" width="226" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Percentage change in Karnofsky Score compared to before intervention</span></span>'''</span>
 +
 
 +
| style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">After intervention</span></span></span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">19.7 +/- 9.6</span></span></span></p>
 +
| style="width:83.55pt; border:solid windowtext 1.0pt" width="113" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">4.5 +/- 10.7</span></span></span></p>
 +
| style="width:44.8pt; border:solid windowtext 1.0pt" width="63" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">< 0.001</span></span></span></p>  
 
|-
 
|-
 +
| style="width:167.6pt; border:solid windowtext 1.0pt" width="226" |
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Percentage change in Karnofsky Score compared to before intervention</span></span>'''</span>
 +
 +
| style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">6 months</span></span></span></p>
 +
| style="width:69.35pt; border:solid windowtext 1.0pt" width="94" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">15.3 +/- 14.7</span></span></span></p>
 +
| style="width:83.55pt; border:solid windowtext 1.0pt" width="113" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">2.47 +/- 16.11</span></span></span></p>
 +
| style="width:44.8pt; border:solid windowtext 1.0pt" width="63" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.007</span></span></span></p>
 
|}
 
|}
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Comments'''</span>
 
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">.</span>
 
−
# <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">High drop-out rate due to intolerance of HBOT (7) and long travel distances, and high loss to follow-up with 15 deaths by six months. </span>
 
−
# <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">No definition of ‘standard therapy’. HBOT was probably between 2 and 3 ATA for 2 hours as discussed in the introduction</span>
 
−
# <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Quality of life outcomes reported as percentage change from baseline, rather than raw scores.</span>
 
  
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Appraised by''': D. Smart Saturday 20th August 2011</span>
+
<br/> <span style="font-family: Arial, Helvetica, sans-serif; font-size: 120%;">'''Comments'''</span> <span style="font-family: Arial, Helvetica, sans-serif; font-size: 120%;">.</span>
−
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Email''' : <u>[[mailto:dsmart@utas.edu.au | dsmart@utas.edu.au]]</u></span>
+
 
 +
#<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">High drop-out rate due to intolerance of HBOT (7) and long travel distances, and high loss to follow-up with 15 deaths by six months.</span>
 +
#<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">No definition of ‘standard therapy’. HBOT was probably between 2 and 3 ATA for 2 hours as discussed in the introduction</span>
 +
#<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">Quality of life outcomes reported as percentage change from baseline, rather than raw scores.</span>
 +
 
 +
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Appraised by''': D. Smart Saturday 20th August 2011</span> <span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Email'''&nbsp;: <u>[[mailto:dsmart@utas.edu.au| dsmart@utas.edu.au]]</u></span>
  
 
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Update by:''' December 2020</span>
 
<span style="font-family: Arial,Helvetica,sans-serif; font-size: 120%;">'''Update by:''' December 2020</span>
−
[[File:sumhorsa.gif|center]]
 
  
−
<span style="color: #7c00ff; display: block; font-family: arial,helvetica,sans-serif; font-size: 26px; text-align: center;">'''[[Radiation tissue injury  | BACK]]'''</span>
+
[[File:Sumhorsa.gif|center|Sumhorsa.gif]]
 +
 
 +
<span style="color: #7c00ff; display: block; font-family: arial,helvetica,sans-serif; font-size: 26px; text-align: center;">'''[[Radiation_tissue_injury|BACK]]'''</span>

Revision as of 02:44, 9 July 2019

Hyperbaric oxygen administration decreased side effects and improved quality of life after pelvic irradiation in women.

Bottom line

  1. Hyperbaric oxygen improved symptoms and signs of radiation proctitis in women following pelvic irradiation for cervical cancer.
  2. There was an improvement in both proctosopic and histological findings following HBOT.

Citations 1. Sidik S, Hardjodisastro D, Setiabudy R, Gondowiardjo S. Does hyperbaric oxygen administration decrease side effect and improve quality of life after pelvic radiation? Acta Med Indones 2007;39(4):169-173. 2. Sidik S, Daldiyono H, Setiabudy R, Gondowiardjo S, Yoewona V. Oxygen hyperbaric therapy in patients with radiation proctitis. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy 2007;8(1):1-4.

Three-part clinical question For patients with radiation proctitis following radiotherapy for cervical cancer, does hyperbaric oxygen therapy result in improvement of quality of life and objective evidence of radiation proctitis?

Search Terms Hyperbaric oxygen therapy, radiation proctitis, quality of life

The study Non-blinded randomised controlled trial, intention to treat unclear

The study patients Adult females (<55 years) with cervical cancer stages I – IIIB and irradiation (ex beam and brachytherapy) who had radiation proctitis 1 to 6 months after radiotherapy.

Control group: (n=40, 20 analysed) received standard care (not defined),

Experimental group: (n=35, 26 analysed) as above plus HBOT (regimen not given but minimum 18 sessions).

 

The evidence:

Outcome

Time to outcome

Control Group

Experimental Group

P value

Absence of radiation proctitis

6 months

9/20 (45%)

20/26 (77%)

0.03
(NNT 3)

Non-event outcomes

Outcome

Time to outcome

Control Group

Experimental Group

P value

Percentage change in LENT SOMA Score compared to before intervention

After intervention

44.1+/- 28.2

0.71 +/- 30.2

< 0.001

Percentage change in LENT SOMA Score compared to before intervention

6 months

33.6 +/- 57.6

-19.7 +/- 69.4

0.008

Percentage change in Karnofsky Score compared to before intervention

After intervention

19.7 +/- 9.6

4.5 +/- 10.7

< 0.001

Percentage change in Karnofsky Score compared to before intervention

6 months

15.3 +/- 14.7

2.47 +/- 16.11

0.007


Comments .

  1. High drop-out rate due to intolerance of HBOT (7) and long travel distances, and high loss to follow-up with 15 deaths by six months.
  2. No definition of ‘standard therapy’. HBOT was probably between 2 and 3 ATA for 2 hours as discussed in the introduction
  3. Quality of life outcomes reported as percentage change from baseline, rather than raw scores.

Appraised by: D. Smart Saturday 20th August 2011 Email : [dsmart@utas.edu.au]

Update by: December 2020

Sumhorsa.gif

BACK